Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Individual financial report according to IFRS as at 31 March 2026
Regulatory Filings
2026-04-29 Polish
Publication of the Annual Audited Consolidated Financial Statements of "Sopharma" AD for 2025
Annual Report (ESEF) Classification · 100% confidence FY 2025
2026-04-29 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 95% confidence The document is a current report notifying the sale of the company’s treasury shares under EU Regulation No. 596/2014, detailing the number of shares sold, price, and remaining treasury shares. This matches the category for company transactions in its own shares.
2026-04-29 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 95% confidence The text is a current report under EU market abuse regulation (EU) No 596/2014 notifying the sale of the company’s own treasury shares, detailing number of shares sold, share capital percentages, and transaction value. This matches the definition of a “Transaction in Own Shares” (share buyback/issuance) report.
2026-04-28 English
Notification for sales revenues for March 2026
Regulatory Filings Classification · 67% confidence The document is a short current report under Art. 100t LPOS providing monthly sales figures (March 2026 performance and year‐to‐date updates). It is not a full annual or interim report, nor an earnings release or dividend notice. It is a regulatory announcement of operational data required by the public offering law. It therefore falls under the catch-all “Regulatory Filings” category (RNS).
2026-04-20 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 92% confidence The document is a Current Report under EU MAR Article 17 notifying the market that the company sold treasury shares. It details the number of shares sold, percentage of capital, sale price, and resulting treasury share balance. This constitutes a transaction in the company’s own shares, matching the ‘Transaction in Own Shares’ category (POS).
2026-04-20 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.